20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Candesartan cilexetil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2011-280 - Rev 02
This Chemical Type CEP, issued on December 18, 2017, remains in force until January 30, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 2573 associated with this CEP further emphasizes